Factor XII does not initiate prekallikrein activation on endothelial cells

Thrombosis and Haemostasis

Volumn 80, Issue 1, 1998, Pages 74-81

  Røjkjær, Rasmus ^a   Hasan, Ahmed A K ^b   Motta, Guacyara ^c   Schousboe, Inger ^a   Schmaier, Alvin H ^b,d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12; BOVINE SERUM ALBUMIN; BUFFER; CHROMOGENIC SUBSTRATE; GELATIN; PREKALLIKREIN; SOYBEAN TRYPSIN INHIBITOR; ZINC ION;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; VASCULAR ENDOTHELIUM;

EID: 0031878996     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615142     Document Type: Article

References (40)

1. Wiggins RC, Cochrane CG. The autoactivation of rabbit Hageman factor. J Exp Med 1979; 150: 1122-33.
2. Miller G, Silverberg M, Kaplan AP. Autoactivability of human Hageman factor. Biochem Biophys Res Commun 1980; 92: 803-10.
3. Silverberg M, Dunn JT, Garen L, Kaplan AP. Autoactivation of human Hageman factor: demonstration utilizing a synthetic substrate. J Biol Chem 1980; 255: 7281-6.
4. Schmaier AH, Farber A, Schein R, Sprung C. Structural changes of plasma high molecular weight kininogen after in vitro activation and in sepsis. J Lab Clin Med 1988; 112: 182-92.
5. Kozin F, Cochrane CG. The contact activation system of plasma: Biochemistry and pathophysiology. In: Inflammation: Basic principles and clinical correlates. Gallin JI, Goldstein IM, Snyderman R, eds. New York: Raven Press, Ltd. 1988; pp 101-120.
6. Gurewich V, Johnstone M, Loza J-P, Pannell R. Pro-urokinase and prekallikrein are both associated with platelets. Implications for the intrinsic pathway of fibrinolysis and for therapeutic thrombolysis. FEBS Lett 1993; 318: 317-21.
7. Loza J-P, Gurewich V, Johnstone M, Pannell R. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis. Thromb Haemost 1994; 71: 347-52.
8. Lenich C, Pannell R, Gurewich V. Assembly and activation of the intrinsic fibrinolytic pathway on the surface of human endothelial cells in culture. Thromb Haemost 1995; 74: 698-703.
9. Shimada T, Kato H, Iwanaga S. Accelerating effect of zinc ions on the surface-mediated activation of factor XII and prekallikrein. J Biochem (Tokyo) 1987; 102: 913-21.
10. Shore JD, Day DE, Bock PE, Olson ST. Acceleration of surface dependent autocatalytic activation of blood coagulation factor XII by divalent metal ions. Biochemistry 1987; 26: 2250-8.
11. Schousboe I. The inositol-phospholipid-accelerated activation of prekallikrein by activated factor XII at physiological ionic strength requires zinc ions and high-Mr kininogen. Eur J Biochem 1990; 193: 495-9.
12. Røjkjær R, Schousboe I. The surface dependent autoactivation mechanism of factor XII. Eur J Biochem 1997; 243: 160-6.
13. Bernardo MM, Day DE, Olson ST, Shore JD. Surface-independent acceleration of factor XII activation by zinc ions. I. Kinetic characterization of the metal ion rate enhancement. J Biol Chem 1993; 268: 12468-76.
14. Bernardo MM, Day DE, Halvorson HR, Olson ST, Shore JD. Surface-independent acceleration of factor XII activation by zinc ions. II. Direct binding and fluorescence studies. J Biol Chem 1993; 268: 12477-83.
15. 2+-binding sites in factor XII and its derivatives. Eur J Biochem 1997; 247: 491-6.
16. Schmaier AH, Kuo A, Lundberg D, Murray S, Cines DB. Expression of high molecular weight kininogen on human umbilical vein endothelial cells. J Biol Chem 1988; 263: 16327-33.
17. Meloni FJ, Schmaier AH. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation. J Biol Chem 1991; 266: 6786-94.
18. Gustafson EG, Schmaier AH, Wachtfogel YT, Kaufman N, Kucich U, Colman RW. Human neutrophils contain and bind high molecular weight kininogen. J Clin Invest 1989; 84: 28-35.
19. Reddigari SR, Shibayama T, Brunnee T, Kaplan AP. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. J Biol Chem 1993; 268: 11982-7.
20. Motta G, Røjkjær R, Hasan AAK, Cines DB, Schmaier AH. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: A novel mechanism for contact activation . Blood 1998; 91: 516-28.
21. Lin Y, Harris RB, Yan W, McCrae KR, Zhang H, Colman RW. High molecular weight kininogen peptides inhibit the formation of kallikrein on endothelial cell surfaces and subsequent urokinase-dependent plasmin formation. Blood 1997; 90: 690-7.
22. Fisher CA, Schmaier AH, Addonizio VP, Colman RW. Assay of plasma prekallikrein: comparison of amidolytic, esterolytic, coagulation and immunochemical assays. Blood 1982; 59: 963-70.
23. Hasan AAK, Cines DB, Herwald H, Schmaier AH, Müller-Esterl W. Mapping the cell binding site on high molecular weight kininogen's domain 5. J Biol Chem 1995; 270: 19256-61.
24. Kaufman J, Haaseman M, Modrow S, Muller-Esterl W. Structural dissection of the multidomain kininogens. Fine mapping of the target epitopes of antibodies interfering with their functional properties. J Biol Chem 1993; 268: 9079-91.
25. Schousboe I, Røjkjær R, Lintner R. Functional determination of factor XII in plasma. Clin Appl Thromb Hemost 1996; 2 (2): 123-9.
26. Johnson DA, Gautsch JW, Sportsman JR, Elder JH. Improved technique utilizing nonfat dry milk for analysis of proteins and nucleic acids transferred to nitrocellulose. Gene Anal Tech 1984; 1: 3-8.
27. D'Haese PC, Lamberts LV, Vanheule AO, De Broe ME. Direct determination of zinc in serum by zeeman atomic absorption spectrometry with a graphite furnace. Clin Chem 1992; 38: 2439-43.
28. Prasad AS, Oberleas D. Binding of zinc to amino acids and serum proteins in vitro. J Lab Clin Med 1970; 36: 416-25.
29. Ratnoff OD, Evarson B, Embyry P, Ziats NP, Anderson JM, Emanuelson MM, Malemud CJ. Inhibition of the activation of Hageman factor (factor XII) by human vascular endothelial cell culture supernatates. Proc Natl Acad Sci 1991; 88: 10740-3.
30. Kleniewski J, Donaldson, VH. Endothelial cells produce a substance that inhibits contact activation of coagulation by blocking the activation of Hageman factor. Proc Natl Acad Sci 1993; 90: 198-202.
31. Ratnoff OD, Emanuelson MM, Ziats NP. Inhibition of the activation of Hageman factor (factor XII) by peripheral blood cells. J Clin Invest 1987; 80: 1180-9
32. Ratnoff OD, Gleich GJ, Shurin SB, Kazura J, Everson B, Embury P. Inhibition of the activation of hageman factor (Factor XII) by eosinophils and eosinophilic constituents. Am L Hematol1993; 42: 138-45.
33. Woo J, Cannon DC. In: Clinical Diagnosis and Management Laboratory Methods. Henry JB II, ed. Philadelphia: Saunders 1984; 17ed Ed, pp 16-162.
34. Whitehouse RC, Prasad AS, Rabbani PI, Cossack ZT. Zinc in plasma, neutrophils, lymphocytes and erythrocytes as determined by flameless atomic absorbtion spectrophotometry. Clin Chem 1982; 28: 475-80.
35. Whitehouse RC, Prasad AS, Cossack ZT. Determination of ultrafiltrable zinc in plasma by flameless atomic absorption spectrophotometry. Clin Chem 1983; 29: 1971-7.
36. Cunningham BC, Bass S, Fuh G, Wells JA. Zinc mediation of the binding of human growth hormone to the human prolactin receptor. Science 1990; 250: 1709-12.
37. Foley B, Johnson SA, Hackley B, Smith JC Jr, Halsted JA. Zinc content of human platelets. Proc Soc Exp Biol Med 1968; 128: 266-9.
38. Baker RJ, McNeil JJ, Lander H. Platelet metal levels in normal subjects determined by atomic absorption spectrophotometry. Thromb Haemost 1978; 39: 360-5.
39. Kiem J, Borberg H, Iyengar GV, Kasperek K, Siegers M, Feinendegen LE, Gross R. Elemental composition of platelets. Part II: Water content of normal human platelets and measurements of their concentration of Cu, Fe, K, and Zn by neutron activation analysis. Clin Chem 1979; 25: 705-10.
40. Aktulga A, Ulutin ON. Normal human platelet zinc content and its release. In: Monograph: Platelets. Ulutin ON, ed. Amsterdam, Excerpta Medica; 1975.